ViaNova
Enterprise number 0565990842 · Active (000 Normale toestand)
ViaNova is a besloten vennootschap registered in Rixensart, Belgium, incorporated on 28 Oct 2014. Its registered activity is speur- en ontwikkelingswerk op biotechnologisch gebied.
Company details
- Enterprise number
- 0565990842 · official register
- Status
- 000 Normale toestand
- Legal form
- Besloten Vennootschap
- Incorporated
- 28 Oct 2014 (12 years)
- Registered address
- 1330 Rixensart
- Province
- Walloon Brabant
- Activity
- 72110 Speur- en ontwikkelingswerk op biotechnologisch gebied
- Industry
- Scientific research and development
- Accounts overdue
- Yes
Insolvency and register events
No insolvency or liquidation events on record.
Similar companies in Walloon Brabant
- "CLINICAL & QUALITY SUPPORT" Villers-la-Ville
- ABAXYS THERAPEUTICS Villers-la-Ville
- ACADEMIC MEDICAL INTERDISCIPLINARY RESEARCH FOUNDATION - RECHERCHE ACADEMIQUE MEDICALE INTERDISCIPLINAIRE FOUNDATION Lasne
- ADBDL Médecine et Sciences médicales Wavre
- ALANINE Lasne
- ALLSIGHTSAFRICA Orp-Jauche
- ANSERS Perwez
- AQYLA BioVenture Builder Wavre
- ARSALIS Genappe
- ART - OS Waterloo
- ARTLINOW Lasne
- ARXIOS Genappe
Questions about ViaNova
What is the enterprise number of ViaNova?
ViaNova is registered under enterprise number 0565990842 in the official register of Belgium. View it at the official register.
Is ViaNova still active?
Yes. ViaNova is registered as active (status: 000 Normale toestand).
Has ViaNova gone bankrupt or into insolvency?
No insolvency, bankruptcy or administration is recorded for ViaNova in the official data.
When was ViaNova founded?
ViaNova was incorporated on 28 Oct 2014.
Where is ViaNova registered?
ViaNova's registered address is in 1330 Rixensart (Walloon Brabant), Belgium.
Data: FPS Economy – KBO/BCE Open Data (KBO Open Data licence; source: FPS Economy, Crossroads Bank for Enterprises.). National Bank of Belgium – Central Balance Sheet Office web services (NBB-CBSO authentic data, free re-use under the NBB web-service terms.). Last updated 6 Nov 2026.